NOVAVAX INC's ticker is NVAX and the CUSIP is 670002401. A total of 225 filers reported holding NOVAVAX INC in Q1 2023. The put-call ratio across all filers is 1.22 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $465,416 | -4.4% | 64,284 | -1.9% | 0.00% | 0.0% |
| Q2 2023 | $486,762 | +2.4% | 65,513 | -4.5% | 0.00% | 0.0% |
| Q1 2023 | $475,384 | -39.4% | 68,598 | -10.0% | 0.00% | -66.7% |
| Q4 2022 | $783,881 | -44.9% | 76,253 | -2.5% | 0.00% | -40.0% |
| Q3 2022 | $1,423,000 | -69.3% | 78,183 | -13.2% | 0.01% | -58.3% |
| Q2 2022 | $4,632,000 | +17.9% | 90,063 | +68.8% | 0.01% | +50.0% |
| Q1 2022 | $3,929,000 | -51.4% | 53,351 | -5.5% | 0.01% | -50.0% |
| Q4 2021 | $8,080,000 | -67.4% | 56,475 | -52.8% | 0.02% | -68.6% |
| Q3 2021 | $24,789,000 | +147.4% | 119,576 | +153.4% | 0.05% | +142.9% |
| Q2 2021 | $10,020,000 | -34.6% | 47,194 | -44.1% | 0.02% | -36.4% |
| Q1 2021 | $15,321,000 | +53.3% | 84,500 | -5.7% | 0.03% | +43.5% |
| Q4 2020 | $9,991,000 | -4.4% | 89,600 | -7.2% | 0.02% | -11.5% |
| Q3 2020 | $10,456,000 | +32.2% | 96,500 | +1.7% | 0.03% | +18.2% |
| Q2 2020 | $7,910,000 | +1073.6% | 94,900 | +91.3% | 0.02% | +1000.0% |
| Q1 2020 | $674,000 | +326.6% | 49,600 | +83.9% | 0.00% | – |
| Q2 2019 | $158,000 | – | 26,964 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 132,500 | $18,549,000 | 4.18% |
| OPTIMAS CAPITAL Ltd | 27,800 | $2,047,000 | 1.92% |
| RA Capital Management | 692,794 | $51,024,000 | 1.11% |
| Mendel Capital Management LLC | 13,689 | $1,008,000 | 0.95% |
| Rock Springs Capital Management LP | 448,200 | $33,010,000 | 0.83% |
| SECTORAL ASSET MANAGEMENT INC | 50,500 | $3,719,000 | 0.66% |
| TOBAM | 173,685 | $12,792,000 | 0.64% |
| SECTOR GAMMA AS | 38,324 | $2,823,000 | 0.61% |
| HAP Trading, LLC | 212,100 | $12,723,000 | 0.53% |
| Parametrica Management Ltd | 9,539 | $703,000 | 0.52% |